Karyopharm Therapeutics shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Karyopharm Therapeutics by Candriam Luxembourg S.C.A.
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $459k | 531k | 0.87 |
2023-09-30 | $1.5M | 1.1M | 1.34 |
2023-06-30 | $2.6M | 1.4M | 1.80 |
2023-03-31 | $6.0M | 1.5M | 3.89 |
2022-12-31 | $5.2M | 1.5M | 3.40 |
2022-09-30 | $14M | 1.3M | 10.64 |
2022-06-30 | $0 | 1.2M | 0.00 |
2022-03-31 | $9.8M | 1.3M | 7.37 |
2021-12-31 | $0 | 878k | 0.00 |
2021-09-30 | $4.2M | 718k | 5.82 |
2021-06-30 | $0 | 718k | 0.00 |
2021-03-31 | $0 | 952k | 0.00 |
2020-12-31 | $20M | 952k | 20.83 |
2020-09-30 | $15M | 523k | 27.78 |
2020-06-30 | $0 | 260k | 0.00 |
2020-03-31 | $16M | 845k | 18.74 |
2019-12-31 | $17k | 845k | 0.02 |
2019-09-30 | $11k | 1.1M | 0.01 |
2019-06-30 | $12M | 1.9M | 5.96 |
2019-03-31 | $11M | 1.9M | 5.84 |
2018-12-31 | $17M | 1.8M | 9.37 |
2018-09-30 | $19M | 1.1M | 17.03 |
2018-06-30 | $8.4M | 492k | 16.99 |
2018-03-31 | $3.0M | 220k | 13.42 |
2017-12-31 | $3.9M | 403k | 9.60 |
2017-09-30 | $5.6M | 510k | 10.98 |
2017-06-30 | $4.0M | 438k | 9.05 |
2017-03-31 | $2.2M | 172k | 12.84 |
2016-12-31 | $3.7M | 390k | 9.40 |
2016-09-30 | $2.6M | 270k | 9.73 |
2016-06-30 | $1.1M | 160k | 6.71 |
2016-03-31 | $1.7M | 187k | 8.87 |
2015-12-31 | $2.5M | 191k | 13.25 |
2015-09-30 | $1.7M | 161k | 10.53 |
2015-06-30 | $3.6M | 133k | 27.21 |
2015-03-31 | $8.2M | 269k | 30.61 |
2014-12-31 | $11M | 298k | 37.43 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.